GLP-1RAs may also influence growth hormone (GH) secretion, which is integral to maintaining lean mass via IGF-1-mediated protein synthesis
Commercial insurance, Medicare, Medicaid, and pharmacy benefit plans generally evaluate coverage based on approved indications, product labeling, plan formularies, prior-authorization criteria, and medical-necessity rules
Within this context, several substrate-dependent metabolic processes may function as rate-limiting determinants of physiological resilience during sustained GLP-1RA therapy (Table 1)
Despite that call to action, the 2025 data shows R&D costs climbing to a record $2.67 billion per asset while clinical cycle times remain stubbornly long
Roles of glucagon-like peptide 1 receptor agonists in immune cell biology and autoimmune/autoinflammatory diseases